Safety and tolerance of palivizumab administration in a large Northern Hemisphere trial

被引：23
|
作者：
Groothius, JR [1 ]
机构：
[1] Abbott Int, No Hemisphere Expanded Access Study Grp, Abbott Pk, IL USA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2001年 / 20卷 / 06期
关键词：
respiratory syncytial virus; premature infants; monoclonal antibodies; bronchopulmonary dysplasia; chronic lung disease; respiratory disease; infectious disease;
D O I：
10.1097/00006454-200106000-00018
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
An Expanded Access Study was conducted to collect additional safety data on palivizumab. Pre-term infants with or without bronchopulmonary dysplasia received palivizumab every 30 days during the respiratory syncytial virus season. Adverse events were low (6.9%) in the 565 subjects. Serious adverse events included hospitalization and 1 case of respiratory syncytial virus bronchiolitis not requiring hospitalization. This study reaffirms the safety and tolerability of palivizumab.
引用
收藏
页码：628 / 630
页数：3
相关论文
共 50 条
  • [21] ON THE LARGE-SCALE IMPACT OF ARID DUST ON PRECIPITATION CHEMISTRY OF THE CONTINENTAL NORTHERN-HEMISPHERE
    SEQUEIRA, R
    ATMOSPHERIC ENVIRONMENT PART A-GENERAL TOPICS, 1993, 27 (10): : 1553 - 1565
  • [22] WAVENUMBER-FREQUENCY ANALYSIS OF LARGE-SCALE TROPOSPHERIC MOTIONS IN EXTRATROPICAL NORTHERN HEMISPHERE
    WILLSON, MAG
    JOURNAL OF THE ATMOSPHERIC SCIENCES, 1975, 32 (03) : 478 - 488
  • [23] Large-Scale Rossby Normal Modes during Some Recent Northern Hemisphere Winters
    Sassi, F.
    Garcia, R. R.
    Hoppel, K. W.
    JOURNAL OF THE ATMOSPHERIC SCIENCES, 2012, 69 (03) : 820 - 839
  • [24] SAFETY AND TOLERANCE AFTER INTRAVENOUS ADMINISTRATION OF 0.3 MMOL KG GD-DTPA - RESULTS OF A RANDOMIZED, CONTROLLED CLINICAL-TRIAL
    NIENDORF, HP
    HAUSTEIN, J
    LOUTON, T
    BECK, W
    LANIADO, M
    INVESTIGATIVE RADIOLOGY, 1991, 26 : S221 - S223
  • [25] Safety and tolerance of rapid intravenous administration of loading doses of valproic acid (VPA)
    Young, AM
    Miller, S
    Faught, E
    Burneo, J
    Limdi, NA
    NEUROLOGY, 2004, 62 (07) : A313 - A313
  • [26] SAFETY, TOLERANCE, AND PHARMACOKINETIC EVALUATION OF CEFEPIME AFTER ADMINISTRATION OF SINGLE INTRAVENOUS DOSES
    BARBHAIYA, RH
    FORGUE, ST
    GLEASON, CR
    KNUPP, CA
    PITTMAN, KA
    WEIDLER, DJ
    MARTIN, RR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) : 1118 - 1122
  • [27] Co-administration of desferrioxamine B with artesunate in malaria: An assessment of safety and tolerance
    Looareesuwan, S
    Wilairatana, P
    Vannaphan, S
    Gordeuk, VR
    Taylor, TE
    Meshnick, SR
    Brittenham, GM
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1996, 90 (05): : 551 - 554
  • [28] TOLERANCE AND SAFETY OF CEFMETAZOLE FOLLOWING INTRAMUSCULAR ADMINISTRATION TO HEALTHY MALE-VOLUNTEERS
    NOVAK, E
    PETERS, GR
    KO, H
    GRIFFITH, DL
    PAXTON, LM
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1991, 49 (03): : 540 - 554
  • [29] COMPARATIVE EFFECTIVENESS, SAFETY AND TOLERANCE OF MEZLOCILLIN AND TICARCILLIN - A PROSPECTIVE RANDOMIZED TRIAL
    RAMIREZRONDA, CH
    GUTIERREZ, J
    BERMUDEZ, RH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 9 : 125 - 129
  • [30] A novel disposable, transnasal esophagoscope: a pilot trial of feasibility, safety, and tolerance
    Chung, J. W.
    Park, S.
    Chung, M. J.
    Park, J. Y.
    Park, S. W.
    Chung, J. B.
    Song, S. Y.
    ENDOSCOPY, 2012, 44 (02) : 207 - 210
12345